GRAFted Patients' anxieTY Report
- Conditions
- Autologous Transplant Indication
- Interventions
- Other: HAD (Hospital Anxiety and Depression) scale
- Registration Number
- NCT03675997
- Lead Sponsor
- Institut de Cancérologie de la Loire
- Brief Summary
Autograft is a technique requiring several weeks of hospitalization in a protected environment and can be a source of anxiety of different natures for patients. In this study, level of anxiety will be reported weekly throughout hospitalizations for autologous transplant, to detect the most stressful period.
- Detailed Description
Autograft is one of hematological malignancies treatment, such as lymphoma and myeloma. This technique requires several weeks of hospitalization in a protected environment and can be a source of anxiety of different natures for patients. According to the medical and scientific report of the Biomedicine Agency in 2016, 3 043 patients were involved in an autologous transplant, which represents a significant number of patients potentially exposed to these types of anxiety.
That is why it will be interesting in this study to report weekly the level of anxiety throughout their hospitalization for the autologous transplant, to detect the most stressful period.
A validated questionnaire will be used: the HAD (Hospital Anxiety and Depression) scale of anxiety and depression.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
- Autograft indication according to the Multidisciplinary Concertation Meeting
- Incapacity to complete surveys
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Autografted patients HAD (Hospital Anxiety and Depression) scale Patients hospitalized in the hematological department of the Institute will complete the first day of conditioning and then weekly HAD (Hospital Anxiety and Depression) scale.
- Primary Outcome Measures
Name Time Method Anxiety and depression measure 30 days The aim of this study is to measure patients anxiety and depression, using the HAD : Hospital Anxiety and Depression scale.
Scores of the HAD scale can be defined as:
* By adding the points of the answers: 1, 3, 5, 7, 9, 11, 13: we obtain the "Total A" which corresponds to the measure of the anxiety, then:
* 7 or less: absence of symptomatology;
* 8 to 10: doubtful symptomatology;
* 11 and above: certain symptomatology.
* By adding the points of the answers: 2, 4, 6, 8, 10, 12, 14: we obtain the "Total B" which corresponds to the measure of the depression, then:
* 7 or less: absence of symptomatology;
* 8 to 10: doubtful symptomatology;
* 11 and above: certain symptomatology.
The minimal score is 0 and the maximal total score is 42.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Institut de Cancérologie Lucien Neuwirth
🇫🇷Saint-Priest-en-Jarez, France